ARR three-lens brief
Evidence-based stock research on ARR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.10% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -2.10% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 3.7 — trading at a value multiple.
- Analyst mean target $18.38 — 16% above current (4 analysts).
- Debt-to-equity of 757% — balance-sheet-heavy.
ARR closed at $15.83 (-2.10%) as of 2026-09-11. Market cap: $2.24B. P/E (trailing) 3.7. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 3.7 — trading at a value multiple.; analyst mean target $18.38 — 16% above current (4 analysts).. Concerns: moved -2.10% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $76.82M, net income $111.55M.
Why three lenses on ARR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARR brief"></iframe>